Skip to main content

Advertisement

Log in

Human Adipose Tissue Derived Pericytes Increase Life Span in Utrn tm1Ked Dmd mdx/J Mice

  • Published:
Stem Cell Reviews and Reports Aims and scope Submit manuscript

Abstract

Duchenne muscular dystrophy (DMD) is still an untreatable lethal X-linked disorder, which affects 1 in 3500 male births. It is caused by the absence of muscle dystrophin due to mutations in the dystrophin gene. The potential regenerative capacity as well as immune privileged properties of mesenchymal Stem Cells (MSC) has been under investigation for many years in an attempt to treat DMD. One of the questions to be addressed is whether stem cells from distinct sources have comparable clinical effects when injected in murine or canine muscular dystrophy animal models. Many studies comparing different stem cells from various sources were reported but these cells were obtained from different donors and thus with different genetic backgrounds. Here we investigated whether human pericytes obtained from 4 different tissues (muscle, adipose tissue, fallopian tube and endometrium) from the same donor have a similar clinical impact when injected in double mutant Utrn tm1Ked Dmd mdx/J mice, a clinically relevant model for DMD. After a weekly regimen of intraperitoneal injections of 106 cells per 8 weeks we evaluated the motor ability as well as the life span of the treated mice as compared to controls. Our experiment showed that only adipose tissue derived pericytes are able to increase significantly (39 days on average) the life span of affected mice. Microarray analysis showed an inhibition of the interferon pathway by adipose derived pericytes. Our results suggest that the clinical benefit associated with intraperitoneal injections of these adult stem cells is related to immune modulation rather than tissue regeneration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig 1
Fig 2
Fig 3
Fig 4
Fig 5
Fig 6
Fig 7

Similar content being viewed by others

References

  1. Mercuri, E. (2013). Muntoni F. Lancet: Muscular dystrophies.

    Google Scholar 

  2. Manzur A, Kuntzer T, Pike M et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane database of systematic reviews (Online). 2008.

  3. Biggar, W., Harris, V., Eliasoph, L., et al. (2006). Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscular disorders : NMD., 16, 249–255.

    Article  CAS  PubMed  Google Scholar 

  4. Partridge, T. (1991). Animal models of muscular dystrophy–what can they teach us? Neuropathology and applied neurobiology., 17, 353–363.

    Article  CAS  PubMed  Google Scholar 

  5. Deconinck, A., Rafael, J., Skinner, J., et al. (1997). Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell., 90, 717–727.

    Article  CAS  PubMed  Google Scholar 

  6. Lazarus, H., Haynesworth, S., Gerson, S., et al. (1995). Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone marrow transplantation., 16, 557–564.

    CAS  PubMed  Google Scholar 

  7. Caplan, A., & Dennis, J. (2006). Mesenchymal stem cells as trophic mediators. Journal of cellular biochemistry., 98, 1076–1084.

    Article  CAS  PubMed  Google Scholar 

  8. Le Blanc, K., Tammik, L., Sundberg, B., et al. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scandinavian journal of immunology., 57, 11–20.

    Article  PubMed  Google Scholar 

  9. Gao, J., Dennis, J., Muzic, R., et al. (2001). The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells, tissues, organs., 169, 12–20.

    Article  CAS  PubMed  Google Scholar 

  10. Crisan, M., Yap, S., Casteilla, L., et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. CELL STEM CELL., 3, 301–313.

    Article  CAS  PubMed  Google Scholar 

  11. Dellavalle, A., Sampaolesi, M., Tonlorenzi, R., et al. (2007). Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nature cell biology., 9, 255–267.

    Article  CAS  PubMed  Google Scholar 

  12. Sacchetti, B., Funari, A., Michienzi, S., et al. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell., 131, 324–336.

    Article  CAS  PubMed  Google Scholar 

  13. Caplan, A. (2008). All MSCs are pericytes? Cell stem cell., 3, 229–230.

    Article  CAS  PubMed  Google Scholar 

  14. de la Garza-Rodea, A., van der Velde-van, D. I., Boersma, H., et al. (2012). Myogenic properties of human mesenchymal stem cells derived from three different sources. Cell transplantation., 21, 153–173.

    Article  PubMed  Google Scholar 

  15. Kennel, P., Fonteneau, P., Martin, E., et al. (1996). Electromyographical and motor performance studies in the pmn mouse model of neurodegenerative disease. Neurobiology of disease., 3, 137–147.

    Article  CAS  PubMed  Google Scholar 

  16. Alcoser, S., Kimmel, D., Borgel, S., et al. (2011). Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts. BMC biotechnology., 11, 124.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Song, P., Xie, Z., Guo, L., et al. (2012). Human genome-specific real-time PCR method for sensitive detection and reproducible quantitation of human cells in mice. Stem cell reviews., 8, 1155–1162.

    Article  CAS  PubMed  Google Scholar 

  18. Mesa, L., Dubrovsky, A., Corderi, J., et al. (1991). Steroids in Duchenne muscular dystrophy–deflazacort trial. Neuromuscular disorders : NMD., 1, 261–266.

    Article  CAS  PubMed  Google Scholar 

  19. Angelini, C., Pegoraro, E., Turella, E., et al. (1994). Deflazacort in Duchenne dystrophy: study of long-term effect. Muscle & nerve., 17, 386–391.

    Article  CAS  Google Scholar 

  20. Kinali M, Mercuri E, Main M et al. An effective, low-dosage, intermittent schedule of prednisolone in the long-term treatment of early cases of Duchenne dystrophy. Neuromuscular disorders : NMD. 2002;12 Suppl 1:74.

  21. Zucconi, E. (2011). Vieira NM. Jr. et al. Preclinical Studies with Umbilical Cord Mesenchymal Stromal Cells in Different Animal Models for Muscular Dystrophy. Journal of Biomedicine and Biotechnology: Bueno CR.

    Google Scholar 

  22. Vieira N, Bueno C, Brandalise V et al. SJL dystrophic mice express a significant amount of human muscle proteins following systemic delivery of human adipose-derived stromal cells without immunosuppression. Stem cells (Dayton, Ohio). 2008;26:2391–2398.

  23. Pittenger M, Mackay A, Beck S et al. Multilineage potential of adult human mesenchymal stem cells. Science (New York, NY). 1999;284:143–147.

  24. Huang, G. (2009). Gronthos S. Shi S. Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. Journal of dental research., 88, 792–806.

    CAS  Google Scholar 

  25. Zuk, P., Zhu, M., Ashjian, P., et al. (2002). Human adipose tissue is a source of multipotent stem cells. Molecular biology of the cell., 13, 4279–4295.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Lee, D.-H., Joo, S.-D., Han, S.-B., et al. (2011). Isolation and expansion of synovial CD34 (−) CD44 (+) CD90 (+) mesenchymal stem cells: comparison of an enzymatic method and a direct explant technique. Connective tissue research., 52, 226–234.

    Article  CAS  PubMed  Google Scholar 

  27. Secco, M., Moreira, Y., Zucconi, E., et al. (2009). Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood. Stem cell reviews., 5, 387–401.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Rossignoli, F., Caselli, A., Grisendi, G., et al. (2013). Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood. BioMed research international., 2013, 901821.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Jazedje, T., Perin, P., Czeresnia, C., et al. (2009). Human fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures. Journal of translational medicine., 7, 46.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Jin, H., Bae, Y., Kim, M., et al. (2013). Comparative analysis of human mesenchymal stem cells from bone marrow, adipose tissue, and umbilical cord blood as sources of cell therapy. International journal of molecular sciences., 14, 17986–18001.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Hua J, Gong J, Meng H et al. Comparison of different methods for the isolation of mesenchymal stem cells from umbilical cord matrix: proliferation and multilineage differentiation as compared to mesenchymal stem cells from umbilical cord blood and bone marrow. Cell biology international. 2013.

  32. Roobrouck V, Clavel C, Jacobs S et al. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem cells (Dayton, Ohio). 2011;29:871–882.

  33. Secco M, Zucconi E, Vieira N et al. Multipotent stem cells from umbilical cord: cord is richer than blood! Stem cells (Dayton, Ohio). 2008;26:146–150.

  34. Birbrair A, Zhang T, Wang Z-M et al. Role of Pericytes in Skeletal Muscle Regeneration and Fat Accumulation. Stem cells and development. 2013.

  35. Lavasani, M., Robinson, A., Lu, A., et al. (2012). Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nature communications., 3, 608.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Eder Zucconi, Mariane Secco, Tatiana Jazedje, Natássia Vieira, Natale Cavaçana, Naila Lourenço, Michel Naslavsky, Melinda Becari, Bárbara de Bélis, Lúcia Inês and Thiago Olávio for their helpful suggestions throughout the project. Constância Gotto, Vanessa Sato and Wagner Falciano for administrative support. Marta Canovas for her help with the tissue sections and Neide Mascarenhas and co-workers from IPEN for the collaboration regarding animal care. We gratefully acknowledge Prof. Oswaldo Keith Okamoto for the critical reading of this MS. This work was supported by CEPID/FAPESP, INCT and CNPq.

Conflict of Interest

We declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Zatz.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 55 kb)

ESM 2

(DOCX 1112 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Valadares, M.C., Gomes, J.P., Castello, G. et al. Human Adipose Tissue Derived Pericytes Increase Life Span in Utrn tm1Ked Dmd mdx/J Mice. Stem Cell Rev and Rep 10, 830–840 (2014). https://doi.org/10.1007/s12015-014-9537-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12015-014-9537-9

Keywords

Navigation